Capital Research Global Investors Has $532.20 Million Holdings in Cigna Group $CI

Posted by Stanley Muller on Jun 8th, 2026

Capital Research Global Investors cut its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 39.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,933,645 shares of the health services provider’s stock after selling 1,245,656 shares during the period. Capital Research Global Investors’ holdings in Cigna Group were worth $532,197,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Beacon Financial Strategies CORP acquired a new position in Cigna Group during the 4th quarter valued at about $28,000. Collier Financial acquired a new position in Cigna Group during the 3rd quarter valued at about $34,000. Lodestone Wealth Management LLC acquired a new position in Cigna Group during the 4th quarter valued at about $32,000. Creative Financial Designs Inc. ADV lifted its position in Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares during the period. Finally, Activest Wealth Management lifted its position in Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CI has been the topic of a number of research reports. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research report on Friday, May 1st. Royal Bank Of Canada increased their price target on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Jefferies Financial Group cut their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Cantor Fitzgerald increased their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Finally, Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Read Our Latest Analysis on Cigna Group

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Price Performance

NYSE CI opened at $290.17 on Monday. The business has a 50 day simple moving average of $279.58 and a 200 day simple moving average of $277.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $76.76 billion, a price-to-earnings ratio of 12.30, a PEG ratio of 1.12 and a beta of 0.28.

Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the prior year, the business earned $6.74 EPS. Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.